American Century Companies Inc. trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 24.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,072,882 shares of the medical equipment provider’s stock after selling 349,606 shares during the quarter. Intuitive Surgical comprises about 0.6% of American Century Companies Inc.’s investment portfolio, making the stock its 23rd largest holding. American Century Companies Inc. owned approximately 0.94% of Intuitive Surgical worth $615,834,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. Arrow Financial Corp bought a new position in Intuitive Surgical in the 3rd quarter valued at about $115,000. JNBA Financial Advisors acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $115,000. Optimum Investment Advisors boosted its stake in shares of Intuitive Surgical by 189.9% in the 3rd quarter. Optimum Investment Advisors now owns 229 shares of the medical equipment provider’s stock valued at $131,000 after purchasing an additional 150 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $137,000. Finally, Adviser Investments LLC acquired a new stake in shares of Intuitive Surgical in the 2nd quarter valued at approximately $115,000. 84.16% of the stock is currently owned by institutional investors and hedge funds.
NASDAQ:ISRG opened at $519.69 on Wednesday. Intuitive Surgical, Inc. has a one year low of $359.75 and a one year high of $581.12. The company has a market cap of $58.95 billion, a P/E ratio of 72.28, a price-to-earnings-growth ratio of 3.47 and a beta of 1.02.
Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 EPS for the quarter, topping the consensus estimate of $2.66 by $0.17. Intuitive Surgical had a net margin of 22.31% and a return on equity of 18.79%. The business had revenue of $920.90 million for the quarter, compared to the consensus estimate of $916.22 million. During the same period last year, the company earned $2.77 EPS. The firm’s revenue was up 14.0% compared to the same quarter last year. Analysts predict that Intuitive Surgical, Inc. will post 9.52 earnings per share for the current year.
In related news, VP Jamie Samath sold 864 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 23rd. The shares were sold at an average price of $499.21, for a total transaction of $431,317.44. Following the sale, the vice president now directly owns 257 shares in the company, valued at approximately $128,296.97. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Marshall Mohr sold 7,500 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 31st. The stock was sold at an average price of $525.00, for a total transaction of $3,937,500.00. Following the sale, the vice president now owns 17,321 shares in the company, valued at $9,093,525. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 47,086 shares of company stock worth $24,023,337. 2.20% of the stock is owned by corporate insiders.
A number of equities research analysts have recently weighed in on the stock. Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $515.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, July 20th. Royal Bank of Canada set a $550.00 price target on shares of Intuitive Surgical and gave the company a “hold” rating in a research note on Friday, July 20th. Piper Jaffray Companies raised their price target on shares of Intuitive Surgical from $613.00 to $625.00 and gave the company an “overweight” rating in a research note on Wednesday, October 31st. BTIG Research restated a “hold” rating on shares of Intuitive Surgical in a research note on Sunday, July 22nd. Finally, Bank of America raised their price target on shares of Intuitive Surgical from $510.00 to $600.00 and gave the company a “buy” rating in a research note on Tuesday, July 17th. One analyst has rated the stock with a sell rating, four have issued a hold rating and seventeen have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $554.64.
TRADEMARK VIOLATION NOTICE: This article was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/11/07/american-century-companies-inc-sells-349606-shares-of-intuitive-surgical-inc-isrg.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
See Also: Stock Split
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.